Characteristics | Hazard ratio for lymphoid neoplasm | |||
---|---|---|---|---|
Unadjusted† | P-value* | Adjusted†‡ | P-value* | |
Hodgkin’s disease (ICD-10 code = C81) | ||||
Herpes zoster | 3.34 (1.21–9.23) | 0.020 | 3.23 (1.17–8.93) | 0.024 |
Reference | 1.00 | 1.00 | ||
Follicular (nodular) non-Hodgkin’s lymphoma (ICD-10 code = C82) | ||||
Herpes zoster | 0.99 (0.28–3.52) | 0.990 | 0.96 (0.27–3.41) | 0.948 |
Reference | 1.00 | 1.00 | ||
Diffuse non-Hodgkin’s lymphoma (ICD-10 code = C83) | ||||
Herpes zoster | 1.61 (1.06–2.45) | 0.025 | 1.51 (0.99–2.29) | 0.055 |
Reference | 1.00 | 1.00 | ||
Peripheral and cutaneous T cell lymphomas (ICD-10 code = C84) | ||||
Herpes zoster | 1.49 (0.58–3.82) | 0.402 | 1.42 (0.55–3.63) | 0.467 |
Reference | 1.00 | 1.00 | ||
Other and unspecified types of non-Hodgkin’s lymphoma (ICD-10 code = C85) | ||||
Herpes zoster | 1.38 (0.93–2.06) | 0.108 | 1.30 (0.88–1.94) | 0.192 |
Reference | 1.00 | 1.00 | ||
Malignant immunoproliferative diseases (ICD-10 code = C88) | ||||
Herpes zoster | 1.66 (0.58–4.70) | 0.343 | 1.51 (0.53–4.31) | 0.441 |
Reference | 1.00 | 1.00 | ||
Multiple myeloma and malignant plasma cell neoplasm (ICD-10 code = C90) | ||||
Herpes zoster | 2.39 (1.47–3.89) | < 0.001 | 2.17 (1.33–3.54) | 0.002 |
Reference | 1.00 | 1.00 | ||
Lymphoid leukemia (ICD-10 code = C91) | ||||
Herpes zoster | 1.02 (0.34–3.05) | 0.975 | 1.01 (0.34–3.02) | 0.988 |
Reference | 1.00 | 1.00 |